Biotech mogul Soon-Shiong pumps fortune into cancer fight

Dr. Patrick Soon-Shiong has taken part of his fortune made in the biotech game--via multibillion-dollar sales of his companies Abraxis and APP Pharmaceuticals--and spent it on a high-speed rail of sorts to transport genomic data among researchers and medical care facilities around the U.S. Soon-Shiong's recently launched nonprofit, Chan Soon-Shiong Institute for Advanced Health (CSS Institute), is getting millions of dollars from its founders to support an IT infrastructure that could help speed the translation of scientific discoveries into new treatments for cancer and other diseases. Report